BDX

Becton, Dickinson and Company

232.39 USD
+0.09 (+0.04%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Becton, Dickinson and Company stock is up 0.06% since 30 days ago. The next earnings date is Feb 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Nov 18:55 21 Jun, 2024 240.00 PUT 20 6
22 Nov 15:08 15 Mar, 2024 230.00 CALL 17 199
22 Nov 17:19 21 Jun, 2024 240.00 PUT 20 25
24 Nov 16:50 19 Jan, 2024 240.00 PUT 62 902
27 Nov 15:29 17 Jan, 2025 280.00 PUT 20 54
29 Nov 15:20 17 Jan, 2025 260.00 PUT 17 35
04 Dec 16:19 19 Jan, 2024 240.00 PUT 50 932
04 Dec 16:19 19 Jan, 2024 240.00 PUT 89 932
04 Dec 16:22 17 Jan, 2025 175.00 PUT 100 531
07 Dec 20:48 15 Mar, 2024 250.00 CALL 89 98

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis cathetters, vascular care and preparation products, needle-free IV connectors and extensions sets, syringes, pen needles, and other products for diabetes. Its Life Sciences segment provides specimen and blood collection products; other surgical products.

  • Morgan Stanley
    Mon Dec 4, 07:36
    buy
    confirm
  • Piper Sandler
    Fri Nov 10, 16:24
    buy
    confirm
  • Raymond James
    Fri Nov 10, 07:31
    buy
    confirm